Overall, 29 percent of infants born during October 2023 to March 2024 were immunized against respiratory syncytial virus (RSV ...

The American College of Obstetricians and Gynecologists recommends shots for covid, flu, and RSV. "Vaccines continue to be the best tool available for pregnant patients to protect themselves and their ...

The American College of Obstetricians and Gynecologists on Friday reaffirmed support for Covid-19 vaccination during ...

The American Academy of Pediatrics broke with federal guidance by urging COVID-19 vaccination for children as young as six ...

Background: Respiratory Syncytial Virus (RSV) poses a major health threat to older adults, pregnant women, and high-risk populations. We systematically evaluated the efficacy, immunogenicity, and ...

Respiratory syncytial virus hospitalizations were associated with an increased risk for new and worsening cardiovascular events, particularly in patients with comorbidities, highlighting the ...

We thank Jeffrey Wagner for his comments on our real-world investigation of respiratory syncytial virus (RSV) vaccine effectiveness among adults aged 60 years and older in the USA.1 In response to his ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a respiratory ...

New UKHSA data show the RSV vaccine offers strong protection for older adults and infants, although uptake varies by group.

Senate confirms CDC director as top FDA official resigns under political pressure Senate confirmed Susan Monarez to CDC while Vinay Prasad made a quick exit from FDA.